Lucas Montarce, who was appointed as Eli Lilly's top finance chief in September, received $2.9 million in total compensation in 2024. Montarce succeeded Anat Ashkenazi, who left the company ...

Anat Ashkenazi, 52, became chief financial officer of Alphabet in July, after serving as CFO at pharmaceutical company Eli ...

One of the highlights of Eli Lilly's third-quarter results ... with fewer than 10% switching from Trulicity, said Lilly's chief financial officer Anat Ashkenazi on the call. Now, Lilly's focus ...

Eli Lilly has called on financial regulators ... The issue was also alluded to by Lilly’s chief financial officer, Anat Ashkenazi, on the company’s fourth-quarter results call yesterday ...

As revenues for Eli Lilly’s popular weight loss drug Zepbound continue ... while interim CFO Gordon Brooks received $2.7 million. Anat Ashkenazi, who left the company to become CFO at Alphabet in July ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) announced today that Anat Ashkenazi has resigned from her position as Chief... San Francisco, June 5 (IANS) Google (NASDAQ:GOOGL) parent Alphabet ...

ByInvesting.com • Jun 05, 2024 Alphabet names Eli Lilly's Ashkenazi as its new CFO Alphabet (NASDAQ:GOOGL) has appointed Anat Ashkenazi as its new chief financial officer (CFO), bringing on board a ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...

Eli Lilly experienced a 6% increase in price over the last quarter, coinciding with several major developments. The company reported strong financial results, with significant year-over-year ...